Bacterial resistance surveillance in China: A report from Mohnarin 2004-2005

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 27, Issue 8, 2008, Pages 697-708

  Xiao, Y H ^a   Wang, J ^a   Li, Y ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GATIFLOXACIN; GENTAMICIN; IMIPENEM; LATAMOXEF; LEVOFLOXACIN; METICILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULPERAZON; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHINA; ENTEROBACTERIACEAE; ENTEROCOCCUS; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HEALTH SURVEY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHINA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 48449100039     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0494-6     Document Type: Article

References (23)

1. LP Yang L Li J Xiao 2006 Analysis of drug use in 16 hospitals of Chengdu area during 2000-2004 Evaluation Analysis Drug-Use Hospital China 6 5 284 286
2. National Committee for Clinical Laboratory Standards, 6th edn (1997) Methods for dilution antimicrobial susceptible tests for bacteria that grow aerobically. NCCLS approved document M7-A6. NCCLS, Villanova
3. CR Li Y Li PA Zhang 2003 Dissemination and spread of CTX-M extended-spectrum β-lactamases among clinical isolates of Klebsiella pneumoniae in central China Int J Antimicrob Agents 22 521 525
4. CJ Munday J Xiong C Li 2004 Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in the People's Republic of China Int J Antimicrob Agents. 3 175 180
5. GA Jacoby 2005 Mechanisms of resistance to quinolones Clin Infect Dis 41 S120 126
6. A Robicsek GA Jacoby DC Hooper 2006 The worldwide emergence of plasmid-mediated quinolone resistance Lancet Infect Dis 6 629 640
7. KA Fedler DJ Biedenbach RN Jones 2006 Assessment of pathogen frequency and resistance patterns among pediatric isolates: report from the 2004 SENTRY antimicrobial surveillance program on 3 continents Diag Microbiol Infect Dis 56 427 436
8. JT Li Y Li J Wang 2003 Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections Chinese National Journal of Medicine, 83 265 275
9. MR Jacobs D Felmingham PC Appelbaum RN Gruneberg 2003 The Alexander project 1998- 2000: susceptibility of pathogens isolated from community acquired respiratory tract infection to commonly used antimicrobial agents J Antimicrob Chemother 52 229 246
10. SG Jenkins SD Brown DJ Farrell 2008 Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the US: update from PROTEKT US years 1-4 Ann Clin Microbiol Antimicrob 7 1 36
11. B Bozdogan T Bogdanovich K Kosowska MR Jacobs PC Appelbaum 2004 Macrolide resistance in Streptococcus pneumoniae: clonality and mechanisms of resistance in 24 countries Curr Drug Targets Infect Disord 4 169 176
12. JH Song HH Chang JY Suh KS Ko SI Jung WS Oh 2004 Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP) J Antimicrob Chemother. 53 3 457 463
13. C Yao ZB Yu YH Xiao 2005 Study on drug resistance and molecular epidemiology of Streptococcus pneumoniae isolated in Chongqing Chinese J Epidemiology 26 6 431 434
14. RN Jones 2003 Global Epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY antimicrobial surveillance program (1997-2001) Semin Respir Crit Care Med 24 1 121 134
15. HS Sader TR Fritsche RN Jones 2005 Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY antimicrobial surveillance program (1998-2003) Diag Microb Infect Dis 52 265 273
16. Y Hirakata J Matsuda Y Miyazaki S Kamihira S Kawakami Y Miyazawa 2005 Regional variation in the prevalence of extended-spectrum β-lactamase- producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002) Diag Microb & Infect Dis 52 323 329
17. U Serhat M Robert G Herman 2004 Bacteraemia in Europe-antimicrobial susceptibility data from the MYSTIC surveillance program Int J Antimicrobial Agents 23 155 163
18. BR Louis 2006 Antimicrobial resistance in Gram-positive bacteria Am J Med 119 S11 S19
19. JT Li HM Qi Y Li 2005 2002-2003 Bacterial resistance surveillance on Gram-positive cocci isolated from hospital acquired infections and community acquired infections in China Chinese J Lab Med 28 254 265
20. JT Li AJ Weinstein M Yang 2001 Surveillance of bacterial resistance in China (1998-1999) Chinese Natl J Med 81 8 16
21. JT Li Y Li J Wang 2003 Surveillance on drug resistance of gram-negative bacilli isolated from hospital acquired infections and community acquired infections (2000-2001) Chinese National Journal of Medicine 83 1035 1045
22. JT Li Y Li HM Qi 2005 2002-2003 Bacterial resistance surveillance study on Gram-negative bacilli in China Chinese J Lab Med 28 19 29
23. DM Zhu F Wang YY Zhang 2005 Surveillance of bacterial resistance from hospitals in Shanghai in 2003 Chinese J Infection Chemotherapy 5 4 12